«Acantholysis

Below is an extended Acantholysis patents listing. Click here to return to the Acantholysis main in depth entry.

Patents :
US Patent No.	Title
7326694	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
5874531	Identification of self and non-self antigens implicated autoimmune disease
5834290	Recombinant stratum corneum chymotryptic enzyme (SCCE)
5691460	Epidermal surface antigen gene
5686083	Compositions for treating corns and calluses
5637616	Method for treating diseases mediated by proteases
5547989	Compositions for treating corns and calluses
5167649	Drug delivery system for the removal of dermal lesions
4579844	Topical anti-inflammatory drug therapy
4473565	Topical anti-inflammatory drug therapy
4360518	Topical anti-inflammatory drug therapy
4329366	Topical acylaminophenols
4282216	Topical anti-inflammatory drug therapy
5948952	Xeroderma pigmentosum-deficient mouse
5981256	Recombinant stratum corneum chymotryptic enzyme (SCCE)
7312198	Protein compositions for promoting wound healing and skin regeneration
7255861	Preparations for inducing immunotolerance and uses therefor
7232667	Keratinocyte growth factor-2 polynucleotides
7105497	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7084247	Identification of self and non-self antigens implicated in autoimmune diseases
7060868	Autoimmune disease model animal
6987097	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
6693077	Keratinocyte growth factor-2
6680302	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
6540996	Compound screening methods
6399651	Method of treating dermatoses using avermectin compound
6355623	Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
4185100	Topical anti-inflammatory drug therapy

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.